3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Dermatologic
1
Conditions
Neoplasm Metastasis
36
Leukemia, Myeloid, Acute
32
Multiple Myeloma
27
Lymphoma
23
Breast Neoplasms
18
Prostatic Neoplasms
17
Pancreatic Neoplasms
17
Colorectal Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
15
Burkitt Lymphoma
15
Myelodysplastic Syndromes
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Triple Negative Breast Neoplasms
12
Ovarian Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Melanoma
11
Lung Neoplasms
11
Sarcoma
10
Lymphoma, T-Cell
9
Glioma
9
Carcinoma, Non-Small-Cell Lung
9
Neuroblastoma
8
Neoplasms
8
Fallopian Tube Neoplasms
8
Carcinoma, Renal Cell
8
Squamous Cell Carcinoma of Head and Neck
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Follicular
7
Leukemia, Biphenotypic, Acute
7
Endometrial Neoplasms
7
Interventions
pembrolizumab
8
cemiplimab
5
Nivolumab
4
Ipilimumab
4
Blood Specimen Collection
3
lifileucel
2
avelumab
2
aldesleukin
2
Niacinamide
2
Cyclophosphamide
2
toripalimab
1
tislelizumab
1
oxycodone-acetaminophen
1
lenvatinib
1
fludarabine
1
epacadostat
1
encorafenib
1
durvalumab
1
dostarlimab
1
brodalumab
1
binimetinib
1
atezolizumab
1
Vitamin A
1
Surgical Procedures, Operative
1
Sunscreening Agents
1
Standard of Care
1
Specimen Handling
1
Resistance Training
1
Radiotherapy
1
Niacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Biopsy
×
90 days
×
Clear all
NCT07062003
2026-06-04
MBRT1
Mayo Clinic
Phase NA
Recruiting
60 enrolled